Armistice Capital’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Armistice Capital’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,309,000	Closed	-$2.09M	–	295
2023 Q1	$2.09M	Buy	1,309,000 +528,000	+68%	+$1.07M	0.03%	125
2022 Q4	$1.55M	Buy	+781,000	New	+$1.93M	0.03%	122
2021 Q1	–	Sell	-14,533	Closed	-$955K	–	145
2020 Q4	$955K	Buy	+14,533	New	+$948K	0.03%	100

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Armistice Capital's SRGA Position: Q2 2023 in Review

Armistice Capital sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 1,309,000 shares — an estimated $2.09M sold.

Armistice Capital first reported a position in SRGA in Q4 2020 and held it in 3 quarters. The position peaked at $2.09M in Q1 2023. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Armistice Capital reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Armistice Capital sold 1,309,000 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $2.09M.
Armistice Capital first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Armistice Capital's Surgalign Holdings, Inc. Common Stock position peaked at $2.09M in Q1 2023.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.